Loading organizations...
Adaptive Capital Partners is a Singapore-based, early-stage venture capital firm providing capital and strategic support to technology startups. The firm focuses on high-conviction investments, primarily participating in Seed and Series A funding rounds. Their investment thesis spans HealthTech, Life Sciences, and High Tech, aiming to foster innovative companies within these domains.
The firm was established in 2022 by Shi Ying, its Founder and Managing Partner. Its inception reflects an insight into the potential of early-stage technology companies, particularly within the dynamic Southeast Asian ecosystem. Shi Ying leverages her investment background to guide the firm’s strategic direction and portfolio development.
Adaptive Capital Partners backs early-stage technology companies, primarily focused on Singapore-based ventures. Its portfolio operates across HealthTech, Life Sciences, and High Tech, developing solutions from medical devices to AI-enabled platforms. The firm's vision is to be a catalyst for innovation, fostering the growth of groundbreaking companies shaping future technology and its applications.
Adaptive Capital Partners has 1 tracked investment across 1 company. The latest tracked deal is $10.0M Series A in Aktivo Labs in October 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 6, 2023 | Aktivo Labs | $10.0M Series A | Adaptive Capital Partners, Seeds Capital | — |
